A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial.
Saved in:
| Title: | A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial. |
|---|---|
| Authors: | Wong KH; Department of Neurology, University of Utah, Salt Lake City, UT.; Salt Lake City Veterans Affairs Health System Medical Center, Salt Lake City, UT., Day GS; Department of Neurology, Mayo Clinic in Florida, Jacksonville, FL., Torner JC; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA., Cudkowicz M; Department of Neurology, NeuroNEXT Clinical Coordinating Center, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Harvard Medical School, Boston, MA., Coffey CS; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA., Cho HJS; The National Institute of Neurological Disorders and Stroke (NINDS), of the National Institutes of Health, Bethesda, MD., Utz U; The National Institute of Neurological Disorders and Stroke (NINDS), of the National Institutes of Health, Bethesda, MD., Clifford DB; Department of Neurology, Washington University, St. Louis, MO., Katz E; Formerly with Viela Bio at Time of Contributions; Viela Bio Was Subsequently Acquired By Horizon and Later Amgen, Thousand Oaks, CA., Ratchford J; Formerly with Viela Bio at Time of Contributions; Viela Bio Was Subsequently Acquired By Horizon and Later Amgen, Thousand Oaks, CA., Flavin S; Amgen, Thousand Oaks, CA., Dialino-Felix A; Amgen, Thousand Oaks, CA., Dill LM; Amgen, Thousand Oaks, CA., Kamp C; Clinical Materials Services Unit (CMSU) in the Center for Human Experimental Therapeutics (CHET), University of Rochester, Rochester, NY., Klawiter EC; Department of Neurology, NeuroNEXT Clinical Coordinating Center, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Harvard Medical School, Boston, MA., Singleton JR; Department of Neurology, University of Utah, Salt Lake City, UT.; Salt Lake City Veterans Affairs Health System Medical Center, Salt Lake City, UT., Fedler J; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA., Klingner EA; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA., Ecklund D; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA., Klements D; Department of Neurology, NeuroNEXT Clinical Coordinating Center, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Harvard Medical School, Boston, MA., Costigan M; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA., Steinhart E; Department of Neurology, NeuroNEXT Clinical Coordinating Center, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Harvard Medical School, Boston, MA., Pearson B; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA., Desir C; Department of Neurology, NeuroNEXT Clinical Coordinating Center, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Harvard Medical School, Boston, MA., Dalmau JO; IDIBAPS-Hospital Clinic, University of Barcelona, Barcelona, Spain., Titulaer MJ; Department of Neurology, University Erasmus Medical Center, Rotterdam, the Netherlands., Clardy SL; Department of Neurology, University of Utah, Salt Lake City, UT.; Salt Lake City Veterans Affairs Health System Medical Center, Salt Lake City, UT. |
| Source: | Neurology open access [Neurol Open Access] 2025 Jun; Vol. 1 (2). Date of Electronic Publication: 2025 Apr 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health Inc. on behalf of the American Academy of Neurology Country of Publication: United States NLM ID: 9919033199906676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2998-7601 (Electronic) Linking ISSN: 29987601 NLM ISO Abbreviation: Neurol Open Access Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40625668 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wong+KH%22">Wong KH</searchLink>; Department of Neurology, University of Utah, Salt Lake City, UT.; Salt Lake City Veterans Affairs Health System Medical Center, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Day+GS%22">Day GS</searchLink>; Department of Neurology, Mayo Clinic in Florida, Jacksonville, FL.<br /><searchLink fieldCode="AU" term="%22Torner+JC%22">Torner JC</searchLink>; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA.<br /><searchLink fieldCode="AU" term="%22Cudkowicz+M%22">Cudkowicz M</searchLink>; Department of Neurology, NeuroNEXT Clinical Coordinating Center, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Coffey+CS%22">Coffey CS</searchLink>; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA.<br /><searchLink fieldCode="AU" term="%22Cho+HJS%22">Cho HJS</searchLink>; The National Institute of Neurological Disorders and Stroke (NINDS), of the National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Utz+U%22">Utz U</searchLink>; The National Institute of Neurological Disorders and Stroke (NINDS), of the National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Clifford+DB%22">Clifford DB</searchLink>; Department of Neurology, Washington University, St. Louis, MO.<br /><searchLink fieldCode="AU" term="%22Katz+E%22">Katz E</searchLink>; Formerly with Viela Bio at Time of Contributions; Viela Bio Was Subsequently Acquired By Horizon and Later Amgen, Thousand Oaks, CA.<br /><searchLink fieldCode="AU" term="%22Ratchford+J%22">Ratchford J</searchLink>; Formerly with Viela Bio at Time of Contributions; Viela Bio Was Subsequently Acquired By Horizon and Later Amgen, Thousand Oaks, CA.<br /><searchLink fieldCode="AU" term="%22Flavin+S%22">Flavin S</searchLink>; Amgen, Thousand Oaks, CA.<br /><searchLink fieldCode="AU" term="%22Dialino-Felix+A%22">Dialino-Felix A</searchLink>; Amgen, Thousand Oaks, CA.<br /><searchLink fieldCode="AU" term="%22Dill+LM%22">Dill LM</searchLink>; Amgen, Thousand Oaks, CA.<br /><searchLink fieldCode="AU" term="%22Kamp+C%22">Kamp C</searchLink>; Clinical Materials Services Unit (CMSU) in the Center for Human Experimental Therapeutics (CHET), University of Rochester, Rochester, NY.<br /><searchLink fieldCode="AU" term="%22Klawiter+EC%22">Klawiter EC</searchLink>; Department of Neurology, NeuroNEXT Clinical Coordinating Center, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Singleton+JR%22">Singleton JR</searchLink>; Department of Neurology, University of Utah, Salt Lake City, UT.; Salt Lake City Veterans Affairs Health System Medical Center, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Fedler+J%22">Fedler J</searchLink>; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA.<br /><searchLink fieldCode="AU" term="%22Klingner+EA%22">Klingner EA</searchLink>; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA.<br /><searchLink fieldCode="AU" term="%22Ecklund+D%22">Ecklund D</searchLink>; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA.<br /><searchLink fieldCode="AU" term="%22Klements+D%22">Klements D</searchLink>; Department of Neurology, NeuroNEXT Clinical Coordinating Center, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Costigan+M%22">Costigan M</searchLink>; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA.<br /><searchLink fieldCode="AU" term="%22Steinhart+E%22">Steinhart E</searchLink>; Department of Neurology, NeuroNEXT Clinical Coordinating Center, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Pearson+B%22">Pearson B</searchLink>; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA.<br /><searchLink fieldCode="AU" term="%22Desir+C%22">Desir C</searchLink>; Department of Neurology, NeuroNEXT Clinical Coordinating Center, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Dalmau+JO%22">Dalmau JO</searchLink>; IDIBAPS-Hospital Clinic, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Titulaer+MJ%22">Titulaer MJ</searchLink>; Department of Neurology, University Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Clardy+SL%22">Clardy SL</searchLink>; Department of Neurology, University of Utah, Salt Lake City, UT.; Salt Lake City Veterans Affairs Health System Medical Center, Salt Lake City, UT. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229919033199906676%22">Neurology open access</searchLink> [Neurol Open Access] 2025 Jun; Vol. 1 (2). <i>Date of Electronic Publication: </i>2025 Apr 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health+Inc%2E+on+behalf+of+the+American+Academy+of+Neurology%22">Wolters Kluwer Health Inc. on behalf of the American Academy of Neurology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9919033199906676 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2998-7601 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229987601%22">29987601 </searchLink><i>NLM ISO Abbreviation: </i>Neurol Open Access <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40625668 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1212/wn9.0000000000000007 Languages: – Code: eng Text: English Titles: – TitleFull: A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wong KH – PersonEntity: Name: NameFull: Day GS – PersonEntity: Name: NameFull: Torner JC – PersonEntity: Name: NameFull: Cudkowicz M – PersonEntity: Name: NameFull: Coffey CS – PersonEntity: Name: NameFull: Cho HJS – PersonEntity: Name: NameFull: Utz U – PersonEntity: Name: NameFull: Clifford DB – PersonEntity: Name: NameFull: Katz E – PersonEntity: Name: NameFull: Ratchford J – PersonEntity: Name: NameFull: Flavin S – PersonEntity: Name: NameFull: Dialino-Felix A – PersonEntity: Name: NameFull: Dill LM – PersonEntity: Name: NameFull: Kamp C – PersonEntity: Name: NameFull: Klawiter EC – PersonEntity: Name: NameFull: Singleton JR – PersonEntity: Name: NameFull: Fedler J – PersonEntity: Name: NameFull: Klingner EA – PersonEntity: Name: NameFull: Ecklund D – PersonEntity: Name: NameFull: Klements D – PersonEntity: Name: NameFull: Costigan M – PersonEntity: Name: NameFull: Steinhart E – PersonEntity: Name: NameFull: Pearson B – PersonEntity: Name: NameFull: Desir C – PersonEntity: Name: NameFull: Dalmau JO – PersonEntity: Name: NameFull: Titulaer MJ – PersonEntity: Name: NameFull: Clardy SL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2025 Jun Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2998-7601 Numbering: – Type: volume Value: 1 – Type: issue Value: 2 Titles: – TitleFull: Neurology open access Type: main |
| ResultId | 1 |